Deborah J. Wexler MD, MSc
Associate Professor of Medicine, Harvard Medical School; Chief, Diabetes Unit, Massachusetts General Hospital, Boston, MassachusettsDr. Deborah J. Wexler's research focuses on clinical effectiveness in type 2 diabetes. In addition, she is on the Editorial Board of Diabetes Care, and is a reviewer for multiple journals.
Disclosures
Dr. Wexler reports serving on Data Monitoring Committees for trials of oral semaglutide sponsored by Novo Nordisk.
Recent Contributions to PracticeUpdate:
- The Look AHEAD Intensive Lifestyle Intervention Is a Promising Weight Loss Intervention in the US Military
- Employer-Based Online Weight-Management Intervention Effective in Promoting Weight Loss
- Knee and Hip Osteoarthritis Linked to Risk of Diabetes
- ADA 2018: Implications of Large Population Data on Type 2 Diabetes Treatment
- ADA 2018: Renal Disease and Diabetes
- ADA 2018: Diabetes Care Guidelines
- ADA 2018: Cystic Fibrosis Related Diabetes
- ADA Scientific Sessions 2018: Recommendations From Dr. Deborah Wexler
- Long-Term Outcomes Associated With Triple-Goal Achievement in Patients With Type 2 Diabetes
- Cardiovascular Outcomes Associated With Canagliflozin vs Other Non-Gliflozin Antidiabetic Drugs